Test dapivirine vaginal ring for HIV prevention in women
August 11th, 2012
Researchers will launch a large, multinational clinical trial this month to test the effectiveness and extended safety of a vaginal ring containing an experimental antiretroviral drug to prevent HIV infection in women. With a projected 3,476 participants in five countries, the MTN 020 study, otherwise known as, “A Study to Prevent Infection with a Ring for Extended Use (ASPIRE),” aims to determine whether the drug dapivirine can safely prevent HIV infection when continuously released in the vagina from a silicone ring replaced once a month. Results are expected in early 2015.
Related posts:
- Medicare: Discontinues Tenofovir Vaginal Gel in ‘VOICE’ HIV Prevention Study A large-scale clinical trial evaluating whether daily use of an antiretroviral-containing oral tablet or vaginal gel can prevent HIV infection in women is being modified because an interim review found that the gel, an investigational microbicide, was not effective among study participants....
- VOICE HIV prevention study in women A large-scale clinical trial evaluating whether daily use of an oral tablet or vaginal gel containing antiretroviral drugs can prevent HIV infection in women is being modified because an interim review found that the study cannot show that one of the study products, oral tenofovir, marketed under the trade name Viread, is effective....
- Study to test treatment for fatty liver disease in children With the launch of a new clinical trial supported by the National Institutes of Health, researchers are working to determine whether treating children diagnosed with the most severe form of fatty liver disease with a drug called cysteamine will help improve the liver....
- Information for Pregnant Women Working in Education Information for Pregnant Women Working in Education, Child Care, and Health Care Settings Concerning 2009 H1N1 Influenza Virus ...
- Director announces appointment of David M. Murray as Associate Director for Disease Prevention and Director of the Office of Disease Prevention National Institutes of Health Director Francis S. Collins, M.D., Ph.D., announced today the appointment of David M. Murray, Ph.D., as Associate Director for Disease Prevention and Director of the Office of Disease Prevention (ODP). Dr. Murray is expected to join the NIH on September 23, 2012....
- Unprecedented effort to seek, test, and treat inmates with HIV Twelve scientific teams in more than a dozen states will receive National Institutes of Health grants to study effective ways to prevent and treat HIV/AIDS among people in the criminal justice system. The grants, announced today, will be awarded primarily by the National Institute on Drug Abuse (NIDA), with additional support from the National Institute […]...
- MedicareCard urges women to protect their heart health As part of American Heart Month, on Wednesday, Feb. 8, 2012, the National Heart, Lung, and Blood Institute’s (NHLBI’s) The Heart Truth campaign, with the support of the Foundation for the National Institutes of Health (FNIH), will showcase its signature event, the Red Dress Collection 2012 at Mercedes-Benz Fashion Week in New York City....
- Women exposed to DES in the womb face increased cancer risk A large study of the daughters of women who had been given DES, the first synthetic form of estrogen, during pregnancy has found that exposure to the drug while in the womb (in utero) is associated with many reproductive problems and an increased risk of certain cancers and pre-cancerous conditions. The results of this analysis, […]...
- Medicare Card – Traditional ‘Heel Stick’ Test Is Not an Effective Screening Tool for CMV in Newborns A routine screening test for several metabolic and genetic disorders in newborns, the heel-stick procedure, is not effective in screening for cytomegalovirus (CMV)...
- MedicareCard.com – NIH Podcast Shines Light on Prescription Drug Abuse in Women NIH Podcast...
- MedicareCard.com, National Eye Institute Shares Tips to Promote Eye Health During Healthy Vision Month 2010 During Healthy Vision Month this May, the National Eye Institute (NEI), part of the National Institutes of Health, is encouraging Americans to make vision health a priority and schedule an eye exam to help prevent unnecessary vision loss and blindness. Early detection and timely treatment can help save your sight and ensure that you’re seeing […]...
- Vitamin D may improve bone health in those taking anti-HIV drug Vitamin D may help prevent hormonal changes that can lead to bone loss among those being treated for HIV with the drug tenofovir, according to the results of a National Institutes of Health network study of adolescents with HIV....
- Study finds genetic test results do not trigger increased use of health services People have increasing opportunities to participate in genetic testing that can indicate their range of risk for developing a disease. Receiving these results does not appreciably drive up or diminish test recipients’ demand for potentially costly follow-up health services, according to a study performed by researchers at the National Institutes of Health and colleagues at […]...
- Women sought for NIH study of infertility disorder Young women in the Washington, D.C., area who have polycystic ovarian syndrome (PCOS) are encouraged to take part in a study at the National Institutes of Health on the possible role of the adrenal glands in the disorder. MedicareCard.com has been serving consumers for several years with a primary emphasis on Medicare information and assistance. […]...
- Cigarette smoking implicated in half of bladder cancers in women Current cigarette smokers have a higher risk of bladder cancer than previously reported, and the risk in women is now comparable to that in men, according to a study by scientists from the National Cancer Institute (NCI), part of the National Institutes of Health. The report was published on Aug. 16, 2011, in the Journal […]...
Posted in MedicareCard Replacement | Tags: MEDICARECARD REPLACEMENT